The U.S. Food and Drug Administration (FDA) is warning doctors and consumers that a supplement used to treat genetic disorders in children can cause serious harm and in some cases could lead to death....
Before reaching for a bottle of Tylenol, popping a DayQuil pill or downing a dose of Tylenol Cold and Flu this flu season, Americans should know these popular drugs and their generic counterparts may...
FDA officials will again review Pradaxa, one of the best-selling blood thinners on the market that is also linked to accidental, uncontrollable bleeding. The review by the U.S. Food and Drug Administr...
The U.S. Food and Drug Administration in early January approved a new pill from Bristol-Meyers Squibb Co. and AstraZeneca to treat Type 2 diabetes after previously rejecting the drug. FDA officials la...
Laura Yaeger has a proven track record when it comes to representing people harmed by dangerous drugs and medical devices. She has represented thousands of individuals and their families against drug...
Drugmaker Johnson & Johnson is shifting its focus from medical devices and diagnostic equipment to pharmaceuticals, a strategy that will give Merck and Pfizer a good amount of competition this year. A...
The number of total knee replacement surgeries doubled in the U.S during the last decade, a recent study shows. A 2013 report published in the Journal of Bone and Joint Surgery showed that more Americ...
Japanese pharmaceutical company Takeda is dropping plans to develop diabetes drug fasiglifam (TAK-875) because clinical trials showed participants developed dangerous side effects, including possible...
Eli Lilly is banking that new drugs will counter the massive drop in profits from losing exclusivity of its top-selling antidepressant Cymbalta. The FDA already approved six less costly versions of th...
As we say goodbye to 2013, many people make New Year’s resolutions and wish lists for the coming year – especially when it comes to health. Maybe some would like to be healthier, lose weight or change...
